Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) Peptid

IGFBP7 Wirt: Synthetic BP, IHC, WB
Produktnummer ABIN8103137
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) Peptid (ABIN8103137)

Target

IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))

Quelle

  • 6
Synthetic

Applikation

Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
  • Verwendungszweck

    IGFBP7 Peptide
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti-IGFBP7 antibody ( ARP48174_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))

    Hintergrund

    Background Information: IGFBP7 contains 1 Ig-like C2-type (immunoglobulin-like) domain, 1 IGFBP N-terminal domain and 1 Kazal-like domain. It binds IGF-I and IGF-II with a relatively low affinity. IGFBP7 stimulates prostacyclin (PGI2) production.

    Alternative Symbols: FSTL2, IGFBP-7, IGFBP-7v, MAC25, PSF, AGM, TAF, IBP-7, RAMSVPS, IGFBPRP1

    Molekulargewicht

    29kDa

    Gen-ID

    3490

    NCBI Accession

    NP_001544

    UniProt

    Q16270
Sie sind hier:
Chat with us!